Saudi Arabia In-Vitro Diagnostics (IVD) Market Report by Test Types, Products, Application and Company Analysis 2026-2034

Saudi Arabia in-vitro-diagnostics Market Size and Forecast 2026–2034
The Saudi Arabia in vitro diagnostics market is expected to grow smoothly during the forecast period. This is mainly because of the rising prevalence of chronic and infectious diseases. In addition, the spending on healthcare is also a major factor that will boost the growth of the in vitro diagnostics market. Furthermore, the need to diagnose various kinds of diseases effectively is also expected to boost the growth of the in vitro diagnostics market. Therefore, it is expected to grow from an assessed value of US$ 820.36 million in 2025 to US$ 1,173.70 million in 2034, at a CAGR of 4.06% from 2026 to 2034.

Saudi Arabia IVD Market Overview
In vitro diagnostics, on the other hand, refers to certain medical tests that are used to analyze human specimens such as blood, urine, or tissue, among others, that are derived from the human body. In vitro tests are used outside the human body; therefore, we can define them as tests that are used outside the human body to diagnose diseases, track health, and assess the health status of every human being. In vitro diagnostics products refer to certain products that are used, including reagents, kits, devices, and software used in clinical chemistry, immunology, hematology, and molecular diagnostics, among others. In vitro diagnosis is crucial in the early diagnosis of patients.
IVD has received wide acceptance in Saudi Arabia due to the rising prevalence of chronic diseases like diabetes, cardiovascular diseases, cancer, etc., as well as the increased focus on preventive medicine. The initiatives taken by the government of Saudi Arabia, as part of Vision 2030, are aimed at improving healthcare infrastructure as well as diagnostic capabilities in the country. The rising awareness about the importance of early detection, as well as an increase in private labs, is driving demand for IVD.

Growth Drivers of the Saudi Arabia In Vitro Diagnostics Market
Rising Prevalence of Chronic and Lifestyle-Related Diseases
Chronic diseases have now become another major concern among the Saudi population. There exists a high level of hypertension, as about 25% of the population is hypertensive. Also, about 23% of people in Saudi Arabia are affected by diabetes. Cardiovascular and obesity-related disorders are also common. A significant factor contributing to the growth of the Saudi Arabia IVD market is the increase in the number of chronic and lifestyle disorders. Among these, diabetes, heart-related disorders, obesity, and cancers are alarmingly prevalent, mainly because of the lifestyle. These require continuous monitoring, early detection, and frequent testing. These would have contributed to a significant extent to the high demand for diagnostic tests. In addition, awareness about the early detection of diseases among both patients and medical professionals would have also contributed to the high volumes of diagnostic testing. With the rise of managing chronic diseases as a major area of interest for the medical and pharmaceutical sectors, diagnostics and testing solutions have been expanding in the country.

Government Healthcare Investments and Vision 2030 Initiatives
The healthcare transformation initiative, “Vision 2030,” is one of the major driving forces of the IVD industry in Saudi Arabia. The government is investing heavily in the upgrade of hospitals, laboratories, and diagnostic facilities to increase the level of quality and availability of healthcare services. The growth of public and private diagnostic facilities, the advancement of sophisticated diagnostic technologies, and the adoption of digital health technologies are the prominent drivers of the demand for IVDs. The emphasis on preventive care and the early detection of diseases will also lead the adoption of the implementation of diagnostic tests in the market. The continued growth of the diagnostic infrastructure and public-private partnerships, along with foreign investments in the health sector, will increase the demand for in vitro diagnostics in the kingdom of Saudi Arabia. October 2025, The Global Health Exhibition 2025, scheduled to continue in Riyadh, with the announcement of strategic partnerships and investments worth more than $33 billion on the first day of the event, re-establishing Saudi Arabia as a preferred global health investment hub.

Technological Advancements and Growing Adoption of Molecular Diagnostics
Technological innovations have been a key contributor to the expansion of IVD markets across Saudi Arabia. Today, advanced diagnostic technologies like molecular diagnostics, immunological tests, and point-of-care testing are finding widespread interest among users. Molecular diagnostics have the potential to rapidly diagnose infectious agents, genetic factors, and cancer markers. The growing interest in precision medicine is yet another factor that is promoting the use of advanced IVD technologies. Automated and digitalized technologies have greatly improved efficiency and shortened test delays. With a growing trend of adopting advanced IVD technologies, the IVD markets of Saudi Arabia will naturally show steady growth. September 2025, Co-Diagnostics, Inc. today announced that it has entered into a strategic Memorandum of Understanding (MOU) with a regional manufacturing and distribution company headquartered in the Kingdom of Saudi Arabia, to explore a JV license agreement to develop, manufacture, and sell the Company’s Co-Dx intellectual property product line within the Middle East and North African regions, inclusive of the Company’s newly launched Co-Dx™ PCR point-of-care product line.

Challenges of the Saudi Arabia in vitro diagnostics Market
High Cost of Advanced Diagnostic Technologies and Limited Reimbursement
One of the critical challenges in the Saudi Arabia IVD market is the high cost associated with the usage of advanced diagnostic equipment, reagents, and test kits. Molecular diagnostics, genetic analysis, and automated laboratory solutions require high investment and maintenance costs. These may tend to become a limiting factor for smaller hospitals, diagnostic labs, and healthcare facilities, particularly in non-urban regions. Secondly, the reimbursement structure regarding advanced diagnostic procedures is still in the developmental stage, which may also make the reach of such diagnosis difficult. Delays in the procurement of advanced diagnostic equipment in public healthcare facilities due to budgetary constraints may pose a challenge in the Saudi Arabia IVD market.

Dependence on Imports and Regulatory Approval Complexity
The IVD sector in Saudi Arabia is very import-dependent in terms of test equipment and reagents. This places the IVD sector in Saudi Arabia in jeopardy, as issues like supply chain risks, forex fluctuations, and geopolitical risks play a significant role. On the other hand, issues related to the time taken by international cargo shipments can affect test products and laboratory facility. Further, the approval mechanism for IVD products in Saudi Arabia is lengthy and complex, demanding strict compliance with local regulations. Though this helps in ensuring the quality of the product and safety for patients, it can delay access to innovative solutions in the IVD sector.

Saudi Arabia ELISA & CLIA IVD Market
The market for ELISA (Enzyme-Linked Immunosorbent Assay) and CLIA (Chemiluminescent Immunoassay) IVD products in Saudi Arabia is rising steadily due to an increase in demand for accurate diagnostic solutions. ELISA and CLIA are used in the detection of various infectious diseases, hormonal disorders, autoimmune diseases, and cancer. CLIA is gaining prominence in comparison with other techniques due to its higher sensitivity, suitability with automated systems, and reduced turnaround times. Hospitals and large-scale diagnostic centers have started adopting automated ELISA/CLIA systems to increase their efficiency. An increase in the prevalence of various chronic diseases is further contributing to the growth of the ELISA/CLIA IVD market in Saudi Arabia.

Saudi Arabia In Vitro Diagnostics Rapid Test Market
The Saudi Arabian IVD rapid test market continues to grow due to the growing interest in rapid and decentralized diagnostic solutions. Rapid tests are available for infectious diseases, pregnancy, blood glucose, and cardiac markers, among others. They are suitable for emergencies, clinics, and even rural healthcare since they use very simple and low-infrastructure equipment and give results very fast. Increasingly, the COVID-19 pandemic has accelerated the adoption and awareness of rapid diagnostic testing solutions. Initiatives by the government aimed at improving access to health and early diagnosis have also contributed to this market. With the growing importance of point-of-care testing, the rapid test market will also see steady growth in Saudi Arabia.

Saudi Arabia In Vitro Diagnostics Reagents Market
The IVD Reagents market, which is used in Saudi Arabia, is a significant source of revenue. It is a product, which has to be used for the purpose of testing, for all IVD applications. The growing test volume due to the monitoring of chronic diseases and preventive programs is boosting the demand for this product. The need for a constant supply of high-quality products to the laboratories for test accuracy is a major factor. The increased usage of automated systems, which support these products, is also helping to fuel the demand for this product. Even though this product is dependent on imports, it is one segment of growth for the Saudi Arabia IVD market.

Saudi Arabia IVD Clinical Chemistry Market
The Saudi Arabian market is one of the biggest markets for clinical chemistry IVD tests, especially considering the need for regular tests for metabolic disorders, kidney function, liver function, and cardiovascular diseases. Tests including blood glucose, lipid profiling, and the electrolyte profile are essential for the management and diagnosis of chronic conditions like diabetes and cardiovascular diseases. The prevalence of lifestyle diseases is very high, and the need for regular tests will ensure the demand for clinical chemistry tests. The increasing trend of hospitals and labs adopting automation techniques will also increase the demand for clinical chemistry tests. Clinical chemistry plays a significant role in the health sector in Saudi Arabia.

Saudi Arabia Microbiology IVD Market
The microbiology IVD market in Saudi Arabia is driven by the need for precise detection and subsequent management of infectious diseases. Microbiology testing is one of the essential requirements for the detection of various bacterial, viral, and fungal infections. The increase in awareness of various antimicrobial resistance profiles and hospital-acquired infections has led to the growth of the microbiology IVD market. The inclusion of automated culture systems, molecular microbiology, and rapid pathogen detection systems is leading to greater efficiency. There has also been a government emphasis on infection control. Therefore, with the management of infectious diseases being a high priority subject, the microbiology IVD market is growing.

Riyadh IVD Market
The Riyadh market for IVD is the most developed in Saudi Arabia due to the availability of advanced health care facilities in Riyadh. The Riyadh market for IVD is characterized by the availability of a high number of hospitals and medical facilities. As the capital city of Saudi Arabia, Riyadh is where the Saudi Arabian government is investing heavily in the field of health care as part of the Vision 2030 initiative. The high incidence of diseases in Riyadh, particularly chronic diseases such as diabetes and cancer, is also a driving force in the development of the Riyadh IVD market. The Riyadh IVD market is characterized by the adoption of advanced IVD technology.

Jeddah IVD Market
The market in Jeddah, Saudi Arabia, is driven by the well-established private healthcare industry. Moreover, with Jeddah acting as a major commercial center, it contributes to the market. Diagnostic labs, private healthcare facilities, and specialty healthcare provide a major driving force. The large population base and medical tourism industry in Jeddah create the demand for various IVD tests such as infectious disease testing, clinical chemistry, and immunology testing. Jeddah has a well-developed lab infrastructure. It benefits from an import platform facilitated by its ports. There is a rising demand for point-of-care testing due to advancements in rapid diagnostic technology. Jeddah, as part of the healthcare expansion, will remain an important part of the market.

Mecca IVD Market
The market for IVD in Mecca operates within a different dynamic due to the religious destination. There is a large inflow of visitors during Hajj and Umrah seasons. This represents an increase in population during these seasons, consequently creating the demand for IVD products, especially those used in diagnosing infections, emergency medicine, and general health checks. This information indicates that, even though there is an existing healthcare setup, it is limited, as it is compared to Riyadh or Jeddah. The healthcare facilities, which include those setup during seasons of pilgrimage, heavily rely on rapid and microbiology tests. There is also an enhancement in health surveillance activities undertaken by the government during these seasons.

Dhahran IVD Market
The Dhahran IVD market is sustained by a well-established health care milieu for the corporate world and the expatriate community. The need for IVD is fully satisfied by tests for occupational health, chronic patient management, and prevention-oriented health care. A high standard of hospitals and health care facilities is practiced in Dhahran, with good diagnostic techniques, especially in clinical chemistry and immunology. With well-funded health care facilities and insurance, the trend for test volume will be sustained. Though the test volume is less when compared to other cities, the consistent drive for investment in quality health care is responsible for the growing IVD market. Dhahran is a key part of the Saudi Arabian IVD market.

Market Segmentation
Test Types
• ELISA & CLIA
• PCR
• Rapid Test
• Fluorescence Immunoassays (FIA)
• In Situ Hybridization
• Transcription Mediated Amplification
• Sequencing
• Colorimetric Immunoassay
• Radioimmunoassay (RIA)
• Isothermal Nucleic Acid Amplification Technology
• Others

Products
• Reagents
• Instruments
• Services

Application
• Immunochemistry
• Clinical Chemistry
• Hematology
• Coagulation
• Molecular Diagnostics
• Microbiology
• Others

Cities
• Riyadh
• Jeddah
• Dammam
• Dhahran
• Jubail
• Khobar
• Tabuk
• Mecca
• Medina
• Rest of Cities

All companies have been covered with 5 Viewpoints
• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis:
• Roche Diagnostics
• Danaher Corporation
• Abbott Laboratories
• Thermo Fischer Scientific
• Bio–Rad Laboratories, Inc.
• Sysmex Corporation
• Becton
• Biomerieux Show more